Shumway, Stuart D.
Merck & Co., Inc., Rahway, NJ, USA (United States)
4 papers on CoChat
Most cited papers
- Verified
An unbiased oncology compound screen to identify novel combination strategies
O'Neil, J., Benita, Y., Feldman, I., Chenard, M., Roberts, B., Liu, Y., Li, J., Kral, A., Lejnine, S., Loboda, A., et al. (2016) · Molecular Cancer Therapeutics
PI3K/AKT/mTOR signaling in cancerComputational Drug Discovery Methods
Cited by 407
- Verified
Structure of the Cand1-Cul1-Roc1 Complex Reveals Regulatory Mechanisms for the Assembly of the Multisubunit Cullin-Dependent Ubiquitin Ligases
Goldenberg, S. J., Cascio, T. C., Shumway, S. D., Garbutt, K. C., Liu, J., Xiong, Y., & Zheng, N. (2004) · Cell
Ubiquitin and proteasome pathwaysEnzyme Structure and Function
Cited by 280
- Verified
14-3-3β Binds to and Negatively Regulates the Tuberous Sclerosis Complex 2 (TSC2) Tumor Suppressor Gene Product, Tuberin
Shumway, S. D., Li, Y., & Xiong, Y. (2003) · Journal of Biological Chemistry
14-3-3 protein interactionsTuberous Sclerosis Complex Research
Cited by 74
- Verified
Negative Regulation of TSC1-TSC2 by Mammalian D-Type Cyclins
Zacharek, S. J., Xiong, Y., & Shumway, S. D. (2005) · Cancer Research
PI3K/AKT/mTOR signaling in cancerCancer-related Molecular Pathways
Cited by 72
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free